Skip to content

Evotec

US · EVO #3659 by market cap Listed 2021
1.32 -0.13 -8.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 17:47

Price chart

Pre-market 1.37 -5.52%
After-hours 1.34 +1.52%
Overnight 1.41 -2.76%
3.071.321.322026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on EVO?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -43.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall D-

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 1.6% Better than 33%
Net income CAGR (3Y) 36.8% Better than 84%
Free cash flow CAGR (3Y) 33.4% Better than 76%
Profitability D

How much profit the business keeps from each dollar of sales and capital.

Gross margin 14.5% Better than 11%
Operating margin -7.1% Better than 16%
Net margin -13.1% Better than 14%
Return on equity -11.7% Better than 19%
Return on invested capital -7.3% Better than 19%
Momentum D-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -31.6% Better than 17%
6-month return -56.4% Better than 5%
12-month return (ex latest month) -48.1% Better than 3%
Distance below 52-week high 65.9% Better than 8%
Financial Health D

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.1x Better than 57%
Debt to assets 26.1% Better than 47%
Interest coverage -5.0x Better than 17%
Free cash flow / net income 1.5% Better than 0%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -16.46%
1M -10.81%
3M -32.65%
6M -53.52%
YTD -57.14%
1Y -54.48%
3Y -87.46%
5Y -94.42%

Key statistics

Price & volume

Prev close
1.45
Open
1.38
Day range
1.32 - 1.38
Avg price
1.36
Volume
77.59K
Turnover
105.13K
Amplitude
4.14%
52-week range
1.32 - 3.87

Valuation

P/E
-4.15
P/E (TTM)
-2.38
P/B
0.67
EPS
-0.32
Net profit
-113.01M
Net assets
703.67M

Share structure

Market cap
469.11M
Float cap
388.02M
Shares out
355.39M
Float shares
293.95M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2021-11-04
52-week range 0% of range
1.32 3.87

65.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-986.49K net over the window

Short interest

Shares short
63.32K
As of
2026-10-30

Frequently asked questions

What is the current stock price of Evotec (EVO)?

Evotec last traded at 1.32. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Evotec's market cap?

About 469.11M.

What is the P/E ratio of Evotec?

The trailing twelve-month P/E is -2.38, below its own 5-year average of 87.42 — toward the top of its historical range (76.78% percentile). See the Valuation tab for the full history.

Does Evotec pay a dividend?

Evotec does not currently pay a regular dividend.

Is Evotec a buy according to analysts?

The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 5.00, which implies 278.8% upside from the current price. This is not investment advice.

What is Evotec's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Evotec a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 17:47:50 · For reference only, not investment advice and not tailored to your situation.

Evotec discussion 0 comments

Add a comment